Literature DB >> 7576271

Hyperprolactinaemia in patients with pituitary adenomas. The pituitary stalk compression syndrome.

A Kruse1, J Astrup, C Gyldensted, G E Cold.   

Abstract

Hyperprolactinaemia, unexplained by prolactin-production of the tumour is occasionally found in patients with pituitary tumours. This secondary hyperprolactinaemia has been ascribed to a mass effect of the tumour upon the pituitary stalk, obstructing the normal inhibitory hypothalamic influence on the prolactin producing cells. In this study the adenoma volume, amount of suprasellar enlargement of the tumour and the intrasellar pressure were measured in 42 patients operated upon consecutively for pituitary tumours. Secondary hyperprolactinaemia was found in six (14%). There was no difference as regards adenoma volume, amount of suprasellar extension or intrasellar pressure between the group of patients with elevated p-prolactin versus the group with normal p-prolactin. We conclude that mechanisms other than pituitary stalk compression must be considered as the cause of secondary hyperprolactinaemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7576271     DOI: 10.1080/02688699550041089

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  4 in total

1.  The pituitary stalk effect: is it a passing phenomenon?

Authors:  Marvin Bergsneider; Leili Mirsadraei; William H Yong; Noriko Salamon; Michael Linetsky; Marilene B Wang; David L McArthur; Anthony P Heaney
Journal:  J Neurooncol       Date:  2014-02-19       Impact factor: 4.130

2.  Rethinking the stalk effect: a new hypothesis explaining suprasellar tumor-induced hyperprolactinemia.

Authors:  Donal C Skinner
Journal:  Med Hypotheses       Date:  2008-11-22       Impact factor: 1.538

Review 3.  Pituitary metastasis: a clinical overview.

Authors:  Adam Henry; Ailish Nugent; Ian R Wallace; Bode Oladipo; Oonagh Sheehy; Philip C Johnston
Journal:  Ulster Med J       Date:  2021-11-11

4.  Hyperprolactinemia in clinical non-functional pituitary macroadenomas: A STROBE-compliant study.

Authors:  Liang Lyu; Senlin Yin; Yu Hu; Cheng Chen; Yong Jiang; Yang Yu; Weichao Ma; Zeming Wang; Shu Jiang; Peizhi Zhou
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.